| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.30B | -3.0% |
| Cost of Revenue | $9.29B | +1.9% |
| Gross Profit | $5.01B | -10.8% |
| R&D Expense | $965.9M | +19.4% |
| SG&A Expense | $3.79B | -14.3% |
| Operating Income | -$2.66B | — |
| Interest Expense | $471.3M | -14.3% |
| Pre-tax Income | -$3.67B | -488.1% |
| Income Tax | -$150.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.32B | +80.0% |
| Accounts Receivable | $3.03B | -5.9% |
| Inventory | $4.00B | +3.8% |
| Current Assets | $9.79B | +2.8% |
| Total Assets | $37.19B | -10.4% |
| Current Liabilities | $7.09B | +22.8% |
| Long-term Debt | $12.48B | -11.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.32B | +0.6% |
| Capital Expenditures | $378.8M | +16.2% |
| Investing Cash Flow | -$427.7M | -123.8% |
| Financing Cash Flow | -$1.29B | +70.1% |
| Free Cash Flow | $1.94B | -2.0% |
| -1464.5% |
| Net Income | -$3.51B | -454.2% |
| EPS (Basic) | -$3.00 | -466.0% |
| EPS (Diluted) | -$3.00 | -466.0% |
| Total Liabilities |
| $22.48B |
| -1.7% |
| Stockholders' Equity | $14.71B | -21.1% |